Skip to Content
Merck
  • The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway.

The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway.

The Journal of cell biology (2006-02-16)
Jean-Cheng Kuo, Won-Jing Wang, Chung-Chen Yao, Pei-Rung Wu, Ruey-Hwa Chen
ABSTRACT

Death-associated protein kinase (DAPK) is a calmodulin-regulated serine/threonine kinase and possesses apoptotic and tumor-suppressive functions. However, it is unclear whether DAPK elicits apoptosis-independent activity to suppress tumor progression. We show that DAPK inhibits random migration by reducing directional persistence and directed migration by blocking cell polarization. These effects are mainly mediated by an inhibitory role of DAPK in talin head domain association with integrin, thereby suppressing the integrin-Cdc42 polarity pathway. We present evidence indicating that the antimigratory effect of DAPK represents a mechanism through which DAPK suppresses tumors. First, DAPK can block migration and invasion in certain tumor cells that are resistant to DAPK-induced apoptosis. Second, using an adenocarcinoma cell line and its highly invasive derivative, we demonstrate DAPK level as a determining factor in tumor invasiveness. Collectively, our study identifies a novel function of DAPK in regulating cell polarity during migration, which may act together with its apoptotic function to suppress tumor progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Integrin β1 Antibody, clone MB1.2, clone MB1.2, Chemicon®, from rat
Sigma-Aldrich
Anti-Integrin β1 Antibody, activated, clone B44, azide free, clone B44, Chemicon®, from mouse
Sigma-Aldrich
MISSION® esiRNA, targeting human DAPK1